GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raily Aesthetic Medicine International Holdings Ltd (HKSE:02135) » Definitions » Net Cash per Share

Raily Aesthetic Medicine International Holdings (HKSE:02135) Net Cash per Share : HK$-0.18 (As of Jun. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Raily Aesthetic Medicine International Holdings Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Raily Aesthetic Medicine International Holdings's Net Cash per Share for the quarter that ended in Jun. 2023 was HK$-0.18.

The historical rank and industry rank for Raily Aesthetic Medicine International Holdings's Net Cash per Share or its related term are showing as below:

During the past 7 years, the highest Price-to-Net-Cash Ratio of Raily Aesthetic Medicine International Holdings was 15.09. The lowest was 10.32. And the median was 12.71.

HKSE:02135's Price-to-Net-Cash is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 8.16
* Ranked among companies with meaningful Price-to-Net-Cash only.

Raily Aesthetic Medicine International Holdings Net Cash per Share Historical Data

The historical data trend for Raily Aesthetic Medicine International Holdings's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raily Aesthetic Medicine International Holdings Net Cash per Share Chart

Raily Aesthetic Medicine International Holdings Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Cash per Share
Get a 7-Day Free Trial -0.07 0.16 -0.11 -0.13 -0.22

Raily Aesthetic Medicine International Holdings Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.11 -0.11 -0.13 -0.18 -0.22

Competitive Comparison of Raily Aesthetic Medicine International Holdings's Net Cash per Share

For the Medical Care Facilities subindustry, Raily Aesthetic Medicine International Holdings's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Raily Aesthetic Medicine International Holdings's Price-to-Net-Cash Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raily Aesthetic Medicine International Holdings's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Raily Aesthetic Medicine International Holdings's Price-to-Net-Cash falls into.



Raily Aesthetic Medicine International Holdings Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Raily Aesthetic Medicine International Holdings's Net Cash per Share for the fiscal year that ended in Dec. 2022 is calculated as

Net Cash per Share (A: Dec. 2022 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(87.974-152.738--0.227)/480.595
=-0.13

Raily Aesthetic Medicine International Holdings's Net Cash per Share for the quarter that ended in Jun. 2023 is calculated as

Net Cash per Share (Q: Jun. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(65.239-154.787--2.236)/480.595
=-0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Raily Aesthetic Medicine International Holdings  (HKSE:02135) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Raily Aesthetic Medicine International Holdings Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Raily Aesthetic Medicine International Holdings's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Raily Aesthetic Medicine International Holdings (HKSE:02135) Business Description

Traded in Other Exchanges
N/A
Address
No. 290 North Zhongshan Road, 3-5th Floor, Minhang Tower, Gongshu District, Hangzhou, CHN
Raily Aesthetic Medicine International Holdings Ltd is an aesthetic medical service provider in Zhejiang Province, the PRC. It offers a broad range of aesthetic medical services to clients to meet their different aesthetic and anti-aging objectives. The group is organized into business units based on their services and has three reportable operating segments namely Aesthetic medical services which comprise principally inpatient services including surgical services and outpatient services including injection service, dermatology services, and others; and Consulting service segment which comprise principally management consulting services. Aesthetic medical equipment products comprise principally sales of surgical implants and aesthetic medical skincare products.
Executives
Fu Haishu 2201 Interest of corporation controlled by you
Jin Chunmiao 2202 Interest of your spouse
Ruide Consultation Limited 2101 Beneficial owner
Youxin Management Co., Limited 2101 Beneficial owner
Beauty Milkway (hk) Limited
China Orient Asset Management (international) Holding Limited
China Orient Asset Management Co., Ltd.
Dong Yin Development (holdings) Limited
Wise Leader Assets Ltd.
Shang Hai Dong Hua Jian Kang Guan Li He Huo Qi Ye You Xian He Huo
Dong Fang Zi Chan Guan Li Zhong Guo Kong Gu You Xian Gong Si
Shen Zhen Dong Fang Chuang Ye Tou Zi You Xian Gong Si
Shen Zhen Qian Hai Cai Fu Dong Fang Gu Quan Tou Zi Ji Jin Guan Li You Xian Gong Si
Qing Hai Sheng Dong Fang Cang Yi Yao Chan Ye Fa Zhan Ji Jin You Xian He Huo
Qing Hai Sheng Dong Fang Cang Yi Yao Chan Ye Tou Zi Guan Li You Xian Gong Si

Raily Aesthetic Medicine International Holdings (HKSE:02135) Headlines

No Headlines